Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.70 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.63 |
| ▸ | NAMPT | P43490 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9662113 | 1.00 | NAAA (1.00) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL9662549 | 1.00 | NAAA (1.00) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL3155982 | 1.00 | NAAA (1.00) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL10705645 | 1.00 | NAAA (1.00) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL10697836 | 1.00 | NAAA (1.00) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL359901 | 1.00 | NAAA (1.00) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL1648484 | 0.98 | NAAA (0.97) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL3148607 | 0.93 | NAAA (0.88) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL823552 | 0.92 | NAAA (0.84) | NAAATSHRHTTALOX5HPGD | |
| SCHEMBL15820610 | 0.92 | NAAA (0.84) | NAAATSHRHTTALOX5HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1464 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-4477264-A2 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ACTIVE INGREDIENTS | Symrise AG (DE) | 2024-12-18 | — | — | EP | claimed |
| US-20230293404-A1 | Compositions Comprising Natural Polymers and One or More (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-09-21 | — | — | US | claimed |
| CN-116615172-A | Composition comprising a natural polymer and one or more (bio) alkanediols | 西姆莱斯股份公司 | 2023-08-18 | — | — | CN | claimed |
| EP-4103143-A1 | COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2022-12-21 | — | — | EP | claimed |
| WO-2022122132-A1 | COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| WO-2022122890-A1 | COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| EP-1175200-B1 | USE OF NANOSCALAR ANTIMICROBIAL ACTIVE INGREDIENTS IN BODY DEODORANTS | COGNIS IP MAN GMBH (DE) | 2010-11-24 | — | — | EP | claimed |
| EP-1175200-A1 | USE OF NANOSCALAR ANTIMICROBIAL ACTIVE INGREDIENTS IN BODY DEODORANTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2002-01-30 | — | — | EP | claimed |
| WO-2001079405-A1 | USE OF N-OCTYL SALICYLIC ACID AMIDE AND/OR N-DECYL SALICYLIC ACID AMIDE AS ANTIMICROBIAL ACTIVE INGREDIENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-10-25 | — | — | WO | claimed |
| WO-2000066074-A1 | USE OF NANOSCALAR ANTIMICROBIAL ACTIVE INGREDIENTS IN BODY DEODORANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-11-09 | — | — | WO | claimed |
| WO-2000066070-A2 | UTILIZATION OF NANOSCALAR, ANTIMICROBIAL ACTIVE INGREDIENTS IN ORAL AND/OR DENTAL HYGIENE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-11-09 | — | — | WO | claimed |
| EP-0262587-B1 | SALICYLIC ACID AMIDES, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION | Henkel Kommanditgesellschaft auf Aktien (DE) | 1992-01-08 | — | — | EP | claimed |
| US-4795832-A | BACTERICIDE FOR MOUTHWASH, TOOTHPASTE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1989-01-03 | — | — | US | claimed |
| EP-0262587-A2 | Salicylic acid amides, method for their production and their application | Henkel Kommanditgesellschaft auf Aktien (DE) | 1988-04-06 | — | — | EP | claimed |
| EP-4103144-B1 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| US-4795832-A | BACTERICIDE FOR MOUTHWASH, TOOTHPASTE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1989-01-03 | — | — | US | disclosed |
| EP-0262587-A2 | Salicylic acid amides, method for their production and their application | Henkel Kommanditgesellschaft auf Aktien (DE) | 1988-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293404-A1 | Compositions Comprising Natural Polymers and One or More (Bio)-Alkanediols | ACMSD, CUTA, DDC | NAAA 2102/4885TSHR 3904/4885HTT 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.